The Thrombosis and Hemostasis Biomarkers Market is experiencing sustained growth as the global healthcare sector increasingly prioritizes early diagnosis and risk assessment of cardiovascular and thrombotic disorders. Valued at USD 5,482 million in 2024, the market is projected to grow at a CAGR of 6.40% from 2025 to 2032. As clinical laboratories adopt advanced diagnostic platforms a... https://analystviewmarketinsights.com/reports/report-highlight-thrombosis-and-hemostasis-biomarkers-market